{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:06:56Z","timestamp":1791907616790,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.pcad.2018.06.001","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T01:54:47Z","timestamp":1528422887000},"page":"246-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy"],"prefix":"10.1016","volume":"61","author":[{"given":"Robert F.","family":"Kushner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2018.06.001_bb0005","author":"AMA"},{"key":"10.1016\/j.pcad.2018.06.001_bb0010","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/oby.2008.231","article-title":"Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of The Obesity Society","volume":"16","author":"Allison","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.pcad.2018.06.001_bb0015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4158\/EP12160.PS","article-title":"American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine","volume":"18","author":"Mechanick","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.pcad.2018.06.001_bb0020","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1525-1497.2005.0172.x","article-title":"Trends in professional advice to lose weight among obese adults, 1994\u20132000","volume":"20","author":"Jackson","year":"2005","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0025","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.mlr.0000254575.19543.01","article-title":"Trends in obesity-related counseling in primary care: 1995\u20132004","volume":"45","author":"McAlpine","year":"2007","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.pcad.2018.06.001_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/archinternmed.2009.479","article-title":"Tackling obesity. In primary care up to the challenge?","volume":"170","author":"Kushner","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.pcad.2018.06.001_bb0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archinternmed.2011.3","article-title":"Primary care practice equipped to deal with obesity?","volume":"171","author":"Haire-Joshu","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MLR.0b013e3182726c33","article-title":"A silent response to the obesity epidemic. Decline in US physician weight counseling","volume":"51","author":"Kraschnewski","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.pcad.2018.06.001_bb0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ehb.2014.12.003","article-title":"The role of physicians in promoting weight loss","volume":"17","author":"Berning","year":"2015","journal-title":"Econ Hum Biol"},{"key":"10.1016\/j.pcad.2018.06.001_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7846","article-title":"Obesity in the U.S.: what is the best role for primary care?","volume":"350","author":"Ard","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2018.06.001_bb0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ijo.2009.2","article-title":"A proposed clinical staging system for obesity","volume":"33","author":"Sharma","year":"2009","journal-title":"Int J Obes"},{"issue":"9","key":"10.1016\/j.pcad.2018.06.001_bb0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4158\/EP14280.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease","volume":"20","author":"Garvey","year":"2014","journal-title":"Endocr Pract"},{"issue":"Suppl 3","key":"10.1016\/j.pcad.2018.06.001_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.pcad.2018.06.001_bb0070","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.111.039453","article-title":"Lifestyle modification for obesity. New developments in diet, physical activity, and behavior therapy","volume":"125","author":"Wadden","year":"2012","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.pcad.2018.06.001_bb0075","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2018.3060","article-title":"Trends in obesity and severe obesity prevalence in US youth and adults by sex and age. 2007\u20132008 to 2015\u20132016","volume":"319","author":"Hales","year":"2018","journal-title":"J Am Med Assoc"},{"issue":"Suppl 2","key":"10.1016\/j.pcad.2018.06.001_bb0080","first-page":"51S","article-title":"Lung, and Blood Institute (NHLBI). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report","volume":"6","author":"Heart","year":"1998","journal-title":"Obes Res"},{"issue":"25 Suppl 2","key":"10.1016\/j.pcad.2018.06.001_bb0085","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"Suppl 3","key":"10.1016\/j.pcad.2018.06.001_bb0090","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/oby.2009.386","article-title":"The effect of physical activity on body weight","volume":"17","author":"Jakicic","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.pcad.2018.06.001_bb0095","first-page":"459","article-title":"Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults","volume":"43","author":"American College of Sports Medicine","year":"2009","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pcad.2018.06.001_bb0100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa0804748","article-title":"Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates","volume":"360","author":"Saks","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet","volume":"344","author":"Saks","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-144-7-200604040-00007","article-title":"Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial","volume":"144","author":"Elmer","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archinternmed.2009.470","article-title":"Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure. The ENCORE study","volume":"170","author":"Blumenthal","year":"2010","journal-title":"Arch Intern Med"},{"issue":"suppl","key":"10.1016\/j.pcad.2018.06.001_bb0120","first-page":"S38","article-title":"Standards of medical care in diabetes - 2018","volume":"41","author":"Lifestyle Management","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcad.2018.06.001_bb0125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.amjmed.2011.04.024","article-title":"Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors","volume":"124","author":"Nordmann","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa0708681","article-title":"Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet","volume":"359","author":"Shai","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jand.2015.10.031","article-title":"Interventions for the treatment of overweight and obesity in adults","volume":"116","author":"Position of the Academy of Nutrition and Dietetics","year":"2016","journal-title":"J Acad Nutr Diet"},{"issue":"19","key":"10.1016\/j.pcad.2018.06.001_bb0140","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/jama.288.19.2469","article-title":"Patient self-management of chronic disease in primary care","volume":"288","author":"Bodenheimer","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2018.06.001_bb0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1467-789X.2005.00171.x","article-title":"The role of meal replacements in obesity treatment","volume":"26","author":"Keogh","year":"2005","journal-title":"Obes Rev"},{"key":"10.1016\/j.pcad.2018.06.001_bb0150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/oby.2008.637","article-title":"One-year weight losses in the Look AHEAD study: factors associated with success","volume":"17","author":"Wadden","year":"2009","journal-title":"Obesity"},{"issue":"16","key":"10.1016\/j.pcad.2018.06.001_bb0155","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/jama.2010.1503","article-title":"Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women. A randomized trial","volume":"304","author":"Rock","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2018.06.001_bb0160","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(11)61344-5","article-title":"Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomized controlled trial","volume":"378","author":"Jebb","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2018.06.001_bb0165","series-title":"ACSM's guidelines for exercise testing and prescription","author":"American College of Sports Medicine","year":"2006"},{"key":"10.1016\/j.pcad.2018.06.001_bb0170","series-title":"2018 Physical Activity Guidelines Advisory Committee scientific report","author":"2018 Physical Activity Guidelines Advisory Committee","year":"2018"},{"key":"10.1016\/j.pcad.2018.06.001_bb0175","author":"2008 Physical Activity Guidelines for Americans"},{"issue":"2","key":"10.1016\/j.pcad.2018.06.001_bb0180","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1249\/MSS.0b013e3181949333","article-title":"American College of Sports Medicine position stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults","volume":"41","author":"Donnelly","year":"2009","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pcad.2018.06.001_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jada.2010.10.008","article-title":"Self-monitoring in weight loss: a systematic review of the literature","volume":"111","author":"Burke","year":"2011","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.pcad.2018.06.001_bb0190","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. A guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2018.06.001_bb0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.annepidem.2012.01.001","article-title":"Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007\u20132008","volume":"22","author":"Samaranayake","year":"2012","journal-title":"Ann Epidemiol"},{"issue":"10","key":"10.1016\/j.pcad.2018.06.001_bb0200","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2165\/00003495-200565100-00006","volume":"66","author":"Ioannidees-Demos","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.pcad.2018.06.001_bb0210","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.ijo.0801889","article-title":"Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials","volume":"26","author":"Haddock","year":"2002","journal-title":"Int J Obes"},{"key":"10.1016\/j.pcad.2018.06.001_bb0215","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bmj.1.5588.352","article-title":"Comparison of continuous and intermittent anorectic therapy in obesity","volume":"1","author":"Munro","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.pcad.2018.06.001_bb0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1345\/aph.19412","article-title":"Orlistat\u2014a novel weight loss therapy","volume":"35","author":"Lucas","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pcad.2018.06.001_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1467-789X.2004.00125.x","article-title":"A systematic review of the clinical effectiveness of orlistat used for the management of obesity","volume":"5","author":"O'Meara","year":"2004","journal-title":"Obes Rev"},{"key":"10.1016\/j.pcad.2018.06.001_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2018.06.001_bb0235","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/bmj.39385.413113.25","article-title":"Long term pharmacotherapy for obesity and overweight: updated meta-analysis","volume":"335","author":"Rucker","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2018.06.001_bb0240","author":"Guidance for Industry"},{"issue":"3","key":"10.1016\/j.pcad.2018.06.001_bb0245","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1517\/13543784.15.3.257","article-title":"The potential use of selective 5-HT2c agonists in treating obesity","volume":"15","author":"Smith","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pcad.2018.06.001_bb0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","article-title":"Drugs and valvular heart disease","volume":"356","author":"Roth","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Multicenter, placebo-controlled trial of lorcaserin for weight management","volume":"363","author":"Smith","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0260","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1210\/jc.2011-1256","article-title":"A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: The BLOSSOM trial","volume":"96","author":"Fidler","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pcad.2018.06.001_bb0265","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/oby.22081","article-title":"A randomized trial of lorcaserin and lifestyle counseling for maintaining weight loss achieved with a low-calorie diet","volume":"26","author":"Tronieri","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.pcad.2018.06.001_bb0270","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.ijo.0802783","article-title":"A randomized double-blinds placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects","volume":"28","author":"Wilding","year":"2004","journal-title":"Int J Obes"},{"key":"10.1016\/j.pcad.2018.06.001_bb0275","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.pcad.2018.06.001_bb0280","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2018.06.001_bb0285","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"16","key":"10.1016\/j.pcad.2018.06.001_bb0290","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1080\/14656566.2016.1244527","article-title":"An update on naltrexone\/bupropion extended-release in the treatment of obesity","volume":"17","author":"Saunders","year":"2016","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"9741","key":"10.1016\/j.pcad.2018.06.001_bb0295","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"COR-I Study Group. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pcad.2018.06.001_bb0300","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"COR-II study group. A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.pcad.2018.06.001_bb0305","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/oby.2010.147","article-title":"Weight loss with naltrexone SR\/bupropion SR combination therapy as an adjunct to behavioral modification: The COR-BMOD trial","volume":"19","author":"Wadden","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.pcad.2018.06.001_bb0310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"SCALE Obesity and Prediabetes NN8022-1839 Study Group. A randomized, controlled trial of 3.0\u202fmg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0315","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes. The SCALE diabetes randomized clinical trial","volume":"314","author":"Davies","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.pcad.2018.06.001_bb0320","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ijo.2013.120","article-title":"NN8022-1923 Investigators. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study","volume":"37","author":"Wadden","year":"2013","journal-title":"Int J Obes"},{"key":"10.1016\/j.pcad.2018.06.001_bb0325","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3\u202fyears of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomized, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pcad.2018.06.001_bb0330","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.pcad.2018.06.001_bb0335","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss","volume":"365","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2018.06.001_bb0340","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.metabol.2016.02.002","article-title":"Central nervous system regulation of eating: insights from human brain imaging","volume":"65","author":"Farr","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.pcad.2018.06.001_bb0345","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-nutr-071715-050909","article-title":"The neurobiology of \u201cfood addiction\u201d and its implications for obesity treatment and policy","volume":"36","author":"Carter","year":"2016","journal-title":"Annu Rev Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.pcad.2018.06.001_bb0350","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1017\/S0007114500000933","article-title":"Routes to obesity: phenotypes, food choices and activity","volume":"83","author":"Blundell","year":"2000","journal-title":"Br J Nutr"},{"key":"10.1016\/j.pcad.2018.06.001_bb0355","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1467-789X.2010.00714.x","article-title":"Appetite control: methodological aspects of the evaluation of foods","volume":"11","author":"Blundell","year":"2010","journal-title":"Obes Rev"},{"key":"10.1016\/j.pcad.2018.06.001_bb0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/oby.21244","article-title":"Greater hunger and less restraint predict weight loss success with phentermine treatment","volume":"24","author":"Thomas","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/j.pcad.2018.06.001_bb0365","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/oby.22094","article-title":"Effect of lorcaserin alone and in combination with phentermine on food cravings after 12-week treatment: a randomized substudy","volume":"26","author":"Rebello","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.pcad.2018.06.001_bb0370","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ijo.2013.145","article-title":"Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food","volume":"38","author":"Wang","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/j.pcad.2018.06.001_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41366-018-0040-2","article-title":"Effect of combined naltrexone and bupropion therapy on the brain's functional connectivity","author":"Wang","year":"2018","journal-title":"Int J Obes (Lond)."},{"key":"10.1016\/j.pcad.2018.06.001_bb0380","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcad.2018.06.001_bb0385","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.metabol.2016.03.009","article-title":"Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: a randomized, placebo-controlled, crossover trial","volume":"65","author":"Farr","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.pcad.2018.06.001_bb0390","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s12325-016-0414-6","article-title":"Reward-induced eating: therapeutic approaches to addressing food cravings","volume":"33","author":"Rebello","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.pcad.2018.06.001_bb0395","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00592-017-0994-x","article-title":"Tailoring pharmacotherapy to specific eating behaviours in obesity: can recommendations for personalized therapy be made from current data?","volume":"54","author":"Roberts","year":"2017","journal-title":"Acta Diabetol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062018301063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062018301063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T02:28:52Z","timestamp":1571452132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062018301063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0033062018301063"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2018.06.001","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2018.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}